Literature DB >> 17721934

Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5.

Jun Zhang1, Matt A Cerny, Matt Lawson, Ruzbeh Mosadeghi, John R Cashman.   

Abstract

Three functional mouse flavin-containing monooxygenases (mFMOs) (i.e., mFMO1, mFMO3, and mFMO5) have been reported to be the major FMOs present in mouse liver. To examine the biochemical features of these enzymes, recombinant enzymes were expressed as maltose-binding protein fusion proteins (i.e., MBP-mFMO1, MBP-mFMO3, and MBP-mFMO5) in Escherichia coli and isolated and purified with affinity chromatography. The substrate specificity of these three mouse hepatic FMO enzymes were examined using a variety of substrates, including mercaptoimidazole, trimethylamine, S-methyl esonarimod, and an analog thereof, and a series of 10-(N,N-dimethylaminoalkyl)-2-(trifluoromethyl)phenothiazine analogs. The kinetic parameters of the three mouse FMOs for these substrates were compared in an attempt to explore substrate structure--function relationships specific for each mFMO. Utilizing a common phenothiazine substrate for all three enzymes, we compared the pH dependence for the recombinant enzymes under similar conditions. In addition, thermal stability for mFMO1, mFMO3, and mFMO5 enzymes was examined in the presence and absence of NADPH. The results revealed unique features for mFMO5, suggesting possible impact on the functional significance of this abundantly expressed FMO5 isoform in both human and mouse liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721934     DOI: 10.1002/jbt.20176

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  12 in total

1.  Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions.

Authors:  Robert R Reddy; Erik C Ralph; Meike S Motika; Jun Zhang; John R Cashman
Journal:  Drug Metab Dispos       Date:  2010-09-01       Impact factor: 3.922

2.  Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver.

Authors:  Trine Celius; Steven Roblin; Patricia A Harper; Jason Matthews; Paul C Boutros; Raimo Pohjanvirta; Allan B Okey
Journal:  Drug Metab Dispos       Date:  2008-09-02       Impact factor: 3.922

3.  Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Authors:  Meike S Motika; Jun Zhang; Xueying Zheng; Kiersten Riedler; John R Cashman
Journal:  Mol Genet Metab       Date:  2009-02-27       Impact factor: 4.797

4.  Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.

Authors:  Tong Zhang; Ping Yang; Jianchang Wei; Wanglin Li; Junbin Zhong; Huacui Chen; Jie Cao
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

5.  Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice.

Authors:  Swetha Rudraiah; Jamie E Moscovitz; Ajay C Donepudi; Sarah N Campion; Angela L Slitt; Lauren M Aleksunes; José E Manautou
Journal:  Toxicology       Date:  2014-09-02       Impact factor: 4.221

6.  Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.

Authors:  Swetha Rudraiah; Philip R Rohrer; Igor Gurevich; Michael J Goedken; Theodore Rasmussen; Ronald N Hines; José E Manautou
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

7.  The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing.

Authors:  Sandra G Gonzalez Malagon; Anna N Melidoni; Diana Hernandez; Bilal A Omar; Lyndsey Houseman; Sunil Veeravalli; Flora Scott; Dorsa Varshavi; Jeremy Everett; Yugo Tsuchiya; John F Timms; Ian R Phillips; Elizabeth A Shephard
Journal:  Biochem Pharmacol       Date:  2015-06-04       Impact factor: 5.858

8.  Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut Bacteria.

Authors:  Flora Scott; Sandra G Gonzalez Malagon; Brett A O'Brien; Diede Fennema; Sunil Veeravalli; Clarissa R Coveney; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2017-06-23       Impact factor: 3.922

9.  Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.

Authors:  Sandrine P Claus; Tsz M Tsang; Yulan Wang; Olivier Cloarec; Eleni Skordi; François-Pierre Martin; Serge Rezzi; Alastair Ross; Sunil Kochhar; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-10-14       Impact factor: 11.429

10.  Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis.

Authors:  Sunil Veeravalli; Kersti Karu; Flora Scott; Diede Fennema; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2017-10-25       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.